Opexa Therapeutics (OPXA)

Add to Watchlists
Create an Alert
2.47 -0.04  -1.59% NASDAQ May 4, 20:00 Delayed 2m USD
View Full Chart
OPXA Price Chart
View All Events

OPXA Events

Date Type Description
03/14/2017 Earnings Opexa Therapeutics Inc Fourth Quarter Earnings 2016 Release
03/14/2017 Misc Opexa Therapeutics Inc Fourth Quarter Earnings Conference Call 2016
03/14/2016 Earnings Opexa Therapeutics Inc Fourth Quarter Earnings in 2015 Release
03/14/2016 Misc Opexa Therapeutics Inc Fourth Quarter Earnings Conference Call in 2015
11/10/2015 17:15 EST Misc Opexa Therapeutics Inc Third Quarter Earnings Conference Call in 2015
11/10/2015 Earnings Opexa Therapeutics Inc Third Quarter Earnings in 2015 Release
09/29/2015 Splits Ratio: 1:8
08/12/2015 17:00 EDT Misc Opexa Therapeutics Inc Second Quarter Earnings Conference Call in 2015
08/12/2015 Earnings Opexa Therapeutics Inc Second Quarter Earnings in 2015 Release
05/12/2015 16:30 EDT Misc Opexa Therapeutics Inc First Quarter Earnings Conference Call in 2015
View All Performance Charts

OPXA Total Returns Comparison

Advertisement

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.opexatherapeutics.com
  • Investor Relations URL: http://www.opexatherapeutics.com/investors-relations/why-invest/default.aspx
  • HQ Country: United States
  • HQ State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Texas
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: March 14, 2017
  • NAICS Name: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Opexa Therapeutics Inc is engaged in developing personalized immunotherapy to treat illnesses, including multiple sclerosis as well as other autoimmune diseases such as neuromyelitis optica. These therapies are based on proprietary T-cell technology.

OPXA Comparables

Edit

OPXA Excel Add-In Codes

  • Name: =YCI("OPXA","name")
  • Description: =YCI("OPXA","description")
  • Sector: =YCI("OPXA","sector")
  • Industry: =YCI("OPXA","industry")
  • Est. Current Fiscal Year End: =YCI("OPXA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.